Dexmedetomidina y analgesia perioperatoria en niños
| Autor: | L.M. Torres Morera, M. del Carmen Fernández Riobó, M.V. García Palacios, R. Eizaga Rebollar |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
endocrine system
education.field_of_study business.industry Analgesic Population Perioperative Anaesthetic Agent Cochrane Library Critical Care and Intensive Care Medicine Mini review 03 medical and health sciences 0302 clinical medicine Anesthesiology and Pain Medicine 030202 anesthesiology Anesthesia Perioperative analgesia polycyclic compounds medicine 030212 general & internal medicine Dexmedetomidine education business hormones hormone substitutes and hormone antagonists medicine.drug |
| Zdroj: | Revista Española de Anestesiología y Reanimación. 69:487-492 |
| ISSN: | 0034-9356 |
| DOI: | 10.1016/j.redar.2021.03.013 |
| Popis: | Dexmedetomidine (DEX) is an anaesthetic agent that mimics natural deep sleep and produces minimal cardiorespiratory depression. As such, it is a very valuable option in the management of such a challenging population as paediatric patients. The main objective of this mini review was to evaluate the role of DEX as a perioperative analgesic in children receiving anaesthesia. We searched Google, Pubmed, Embase and the Cochrane Library for articles published between 2010 and 2021, and reviewed various of aspects of DEX, such as pharmacology, effectiveness, safety, and the most recent evidence on its clinical use as an analgesic in paediatric anaesthesia. We also include a cost estimate of perioperative analgesia with DEX. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|